Synergy for neonatal meningitis

"Synergy for neonatal meningitis" refers to an adjunctive antimicrobial strategy used alongside primary therapy to manage severe bacterial infection and inflammation of the meninges and subarachnoid space in infants during the first 28 days of life In this population, the central nervous system infection typically arises from hematogenous dissemination of pathogens such as Group B *Streptococcus*, *Escherichia coli*, *Listeria monocytogenes*, or *Enterococcus* species across an immature blood-br...

"Synergy for neonatal meningitis" refers to an adjunctive antimicrobial strategy used alongside primary therapy to manage severe bacterial infection and inflammation of the meninges and subarachnoid space in infants during the first 28 days of life In this population, the central nervous system infection typically arises from hematogenous dissemination of pathogens such as Group B *Streptococcus*, *Escherichia coli*, *Listeria monocytogenes*, or *Enterococcus* species across an immature blood-br...

"Synergy for neonatal meningitis" refers to an adjunctive antimicrobial strategy used alongside primary therapy to manage severe bacterial infection and inflammation of the meninges and subarachnoid space in infants during the first 28 days of life Clinically, neonates present with subtle and nonspecific features—such as temperature instability, lethargy, poor feeding, apnea, irritability, or seizures—rather than classic signs of meningeal irritation

In this population, the central nervous system infection typically arises from hematogenous dissemination of pathogens such as Group B *Streptococcus*, *Escherichia coli*, *Listeria monocytogenes*, or *Enterococcus* species across an immature blood-brain barrier Clinically, neonates present with subtle and nonspecific features—such as temperature instability, lethargy, poor feeding, apnea, irritability, or seizures—rather than classic signs of meningeal irritation

The synergistic therapeutic approach utilizes combination regimens to enhance bactericidal activity, accelerate cerebrospinal fluid sterilization, and counteract high pathogen burdens before de-escalation to targeted monotherapy